Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Clinical features of hypersensitivity developed with tuberculosis treatment

From: Management of type 1 immediate hypersensitivity reactions to antituberculosis drug: succesful desensitization

 

Female

N (%)

Male

N (%)

Total

N (%)

Pruritus

9 (10.2%)

12 (15.7%)

21 (25.9%)

Urticaria

30 (35.8%)

19 (24.7%)

49 (60.5%)

Angioedema

3 (3.7%)

4 (4.8%)

7 (8.5%)

Urticaria + Angioedema

2 (2.5%)

2 (2.5%)

4 (5%)

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us